ClinicalTrials.gg
CompletedNCT00787696Updated Oct 20, 2011

Healthy Teen Girls: HIV Risk Reduction

A Phase 1/2 interventional study of Cognitive-behavioral HIV/STD risk reduction in HIV-infection/Aids, sponsored by Mississippi State University. Completed at 1 site in United States. Open to female participants aged 13 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-10-20.

Sponsored by Mississippi State University · Phase 1/2, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
333
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,671 studies in Acquired Immunodeficiency Syndrome with a site in United States — 112 open to participants now, 154 under way, 9 of them phase 3. Acquired Immunodeficiency Syndrome · United States.

Enrollment
202nd of 1,291
333 · median 60
Started
2003
with 14 others
Phase 1/2
31 of 1,671
5 open now
Registered
771st of 1,671
by date

Among the 1,671 studies in Acquired Immunodeficiency Syndrome with a site in United States, this one is the 202nd largest by enrollment of the 1,291 interventional ones that give a count, is one of 15 that started in 2003, is one of 31 in phase 1/2, and was the 771st registered.

Acquired Immunodeficiency Syndrome

3,039 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 308 are open to participants now.

Browse Acquired Immunodeficiency Syndrome studies →

Open to participants now

112 of the 1,671 studies in Acquired Immunodeficiency Syndrome with a site in United States are open now. Recruiting first, the newest first:

107 more — sign in →

All 112 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 197 Acquired Immunodeficiency Syndrome studies recruiting now, 117 (59%) set no upper age limit and 67 (34%) stop at 75 or younger; 43 take children under 18; 68 take healthy volunteers.

This study: 13 Years to 18 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,671 studies in Acquired Immunodeficiency Syndrome with a site in United States, or all of them as a file.
02

Study summary

This project assesses the efficacy of an HIV prevention program with adolescent females incarcerated in the Mississippi training school for girls. Participants in both the health education control group and the HIV prevention group will increase health knowledge as a result of their participation in the health classes while incarcerated. However, participants in the HIV prevention group will increase their condom application, assertiveness, and communication skills relative to girls in the health education only group. In addition, after release from the training school, participants in the HIV prevention group will report lower sexual risk behaviors and will have lower rates of infection with chlamydia and gonorrhea during the 12-month follow-up period than participants in the health education only group.

Read the detailed description

This study is a longitudinal analysis of STD/HIV exposure among adolescent female offenders in Mississippi, a population that is disproportionately African American, and at higher risk than adolescents in general due to their propensity to engage in a variety of risk-taking behaviors, earlier onset of sexual behaviors, and the greater prevalence of mental disorders, substance abuse disorders, maltreatment, and family dysfunction. Based on social cognitive theory and Fisher and Fisher's (1992) IMB (Information, Motivation, and Behavioral skills) model, we will evaluate a drug abuse related HIV risk reduction intervention and compare outcomes against a STD/HIV information and health education control condition.

Approximately 400 females committed to the state reformatory/training school for girls will be recruited for participation. The research design will consist of alternating cohort/waves of about 50 subjects each. One treatment condition will be administered at a time with a washout period between cohort/waves. Over a three year period, one half of subjects will get 18 hours of STD/HIV prevention and one half will get 18 hours of Health Education. All subjects will receive one individual counseling session designed to enhance motivation for behavioral change just prior to release from training school. Before and after the intervention, subjects' social competency skills, condom application skills, and health knowledge will be measured. Before intervention and at 6-month and 12-month follow-up, self-report measures of alcohol and drug use, condom use, sexual risk behaviors, and measures of victimization, partner risk, condom attitudes, self-efficacy, and communication related to condom use and risk reduction will be collected. Urine tests for the detection of 2 STDs (chlamydia and gonorrhea) will also be performed at admission to Columbia Training School and at 6-month and 12-month follow-up.

03

Conditions studied

  • HIV-infection/Aids

Keywords

  • HIV prevention
  • female adolescent offenders
  • sexual risk reduction
  • alcohol and other drug abuse
04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female, ages 13 to 17 years, committed to Columbia Training School, who provide written informed assent.

Exclusion criteria

Exclusion Criteria:

  • Acute or chronic physically illness that would preclude participation as determined by facility physician; placement in maximum security unit; study participation during a prior commitment
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
333 participants (actual)

Study arms

  • Experimental
    Skills Training

    intervention group received information, motivation and skills training: condom application, assertive communication \& problem solving

    Behavioral: Cognitive-behavioral HIV/STD risk reduction

  • Active comparator
    Health Education

    Comparsion group received information and motivation

    Behavioral: Cognitive-behavioral HIV/STD risk reduction

Interventions

  • BehavioralCognitive-behavioral HIV/STD risk reduction

    18 60-minute group sessions plus 1 individual health and safety planning session

06

What researchers measure

Primary outcomes

  1. number of partners and frequency of sexual risk behaviors

    Sexual behaviors included condom use in the 3 months prior to each assessment. Unprotected sex occasions (USOs) was calculated by subtracting the number of condom-protected vaginal and anal intercourse occasions from the total number of vaginal and anal intercourse occasions. Sex under the influence is the number of times participant reported sexual intercourse after drinking alcohol or using another drug. Safer sex was categorized as sexually abstinent or consistent condom use.

    Time frame: at 6 & 12 months

  2. infection with chlamydia or gonorrhea

    Time frame: one year

Secondary outcomes

  1. reproductive health knowledge

    Assessed as the number of correct answers to 37 treu/false and multiple choice questions

    Time frame: pre and post-intervention

  2. condom application skill

    Measured by observing participants apply and remove a condom from a penile model and a 10-item checklist

    Time frame: pre and post-intervention

  3. Communication skills

    Assessed during three role-play vignettes that place the respondent in a high-risk sexual or drug use situation and asked them to respond to a series of three escalating prompts as though the situation was actually happening.

    Time frame: pre and post-intervention

  4. Perceived barriers to condom use

    assessed using the Condom Barrier Scale (St. Lawrence, Chapdeline, et al., 1999)

    Time frame: at baseline, 6 and 12 month follow-up

07

Study locations

1 site
  • Columbia Training School
    Columbia, Mississippi 39429, United States
08

References and documents

Publications

  • Robertson AA, St Lawrence J, Morse DT, Baird-Thomas C, Liew H, Gresham K. The Healthy Teen Girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav. 2011 Jun;38(3):241-50. doi: 10.1177/1090198110372332. Epub 2011 Mar 10. Erratum In: Health Educ Behav. 2011 Aug;38(4):423. Robertson, Angela R [corrected to Robertson, Angela A]. PubMed 21393623 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2003, a primary completion of Dec 2008 and a completion of Dec 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2008
First posted
Nov 7, 2008
Start
Sep 2003
Primary completionActual
Dec 2008
CompletionActual
Dec 2009
Last update
Oct 20, 2011
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 20, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00787696
Lead sponsor
Mississippi State University
Responsible party
Angela A. Robertson, PhD (Research Professor, Mississippi State University) — Principal investigator
First posted
Nov 7, 2008
Start date
Sep 2003
Primary completion
Dec 2008
Completion
Dec 2009
Last update
Oct 20, 2011

Study contacts

Angela A. Robertson, Ph.D.
principal investigator · Mississippi State University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion